The first-of-its-kind study published last week in the the 'American Journal of Clinical Nutrition' was conducted by Italian researchers among over 1,000 participants.
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
Developed by US firm Merck & Co, Sitagliptin is used to treat Type 2 diabetes, a condition in which blood sugar goes up because the body does not produce or use insulin normally.
The ICMR has called a virtual meeting of pharma companies and NGOs to discuss the high pricing of cancer, diabetic, thyroid drugs, among others, on 17 August.
Munir indicates that he’s willing to go for broke, even if it risks taking his country “and half the world” down with him. It’s important to understand where he is coming from.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Gen Dwivedi framed Op Sindoor not just as retaliation to Pahalgam, but as demonstration of India’s capability to fight multi-domain conflicts with integration between services & agencies.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS